From 21-23 November 2018, the ECDC and network partners organised the annual European Scientific Conference on Applied Infectious Disease Epidemiology: ESCAIDE. This year, the conference was hosted by Malta, at the Hilton Hotel in St. Julian's. The program offered inspiring speakers with a range of perspectives on communicable disease prevention and control.
The conference is coordinated by ECDC since 2007, when it was transformed from the annual EPIET Scientific Seminar (organised by EPIET since 1996) into ESCAIDE.
Among the Keynote speakers opening ESCAIDE were Dr. John Nkengasong (director at the Africa Centres for Disease Control and Prevention, Ethiopia) and Prof. Dr. Christian Drosten (virologist at the Institute of Virology, Campus Charité Mitte, Germany). ECDC Director Andrea Ammon opened the first day by reminding the audience of the conference aims (see picture).
The EPIET Alumni Network (EAN) has been a key partner in co-organising ESCAIDE since the very beginning. On the first day, EAN organised the 'Career Compass', an interactive session where the audience can ask a panel questions on career choices. This year, the panel (see picture on the right) included a wide range of public health experts. Behind the table (from right to left), you see Dr. Chris Barbara (Chairman of the Pathology Department at Mater Dei Hospital in Malta), Dr. Grazia Caleo (Public Health Advisor for the Manson Unit in Medecins Sans Frontieres), Dr. Emilie Perron (Pharmaco-epidemiologist at WHO), Dr. Jane Wheelan (senior epidemiologist at GSK vaccines), Thibaut Jombart (Associate Professor outbreak response analytics, Imperial College London, UK), and Dr. Alastair Donachie (graduating EPIET fellow cohort 2016).
Arnold Bosman (Transmissible) moderated the Career Compass session.
Poster Session 22 on Vaccine Effectiveness (see picture left) included 4 presentations on effectiveness of Pneumococcal Vaccines and one on seasonal influenza.
Sebastian Cortaredona presented how likely it is that vaccinated people with diabetes will re-vaccinate next year. Lukas Richter presented the impact of PCV-10 on children and adults in Austria. Camelia Savulescu (EpiConcept) gave a summary of the effectiveness studies of SpidNet for PCV-13. Larisa Savrasova discussed outcomes six years after the introduction of PCV-10 in Latvia. And Anna Alari gave an overview of geographical analysis of vaccine coverage and pneumococcal meningitis in France.
The session was moderated by Arnold Bosman (Transmissible).